Successful prophylactic treatment for bleeding in a girl with severe hereditary prothrombin deficiency using a prothrombin complex concentrate (Bebulin VH)

J Pediatr Hematol Oncol. 2004 Aug;26(8):480-3. doi: 10.1097/01.mph.0000130220.33907.5a.

Abstract

The authors describe the evaluation and course of severe hereditary prothrombin deficiency in a 14-year-old girl first diagnosed at age 4 years. Detailed is the evolution of her treatment from episodic fresh-frozen plasma after bleeding events to prophylactic home infusions with the prothrombin complex concentrate Bebulin VH. Pharmacokinetic data on factor II recovery and half-life are presented. The patient has been essentially free of abnormal bleeding while on this prophylactic regimen for 17 months, with no toxicities and with a much improved quality of life.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adolescent
  • Blood Coagulation Factors / therapeutic use*
  • Female
  • Hemorrhage / etiology
  • Hemorrhage / prevention & control*
  • Humans
  • Hypoprothrombinemias / drug therapy*
  • Hypoprothrombinemias / genetics
  • Male
  • Pedigree
  • Quality of Life

Substances

  • Blood Coagulation Factors
  • prothrombin complex concentrates